More Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A news
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class ASSE: 600329

"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Notice on Convening the 2nd Extraordinary General Meeting in 2026

Sep 8, 2026 · Issued by Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A via Shanghai Stock Exchange
Notice on Convening the 2nd Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A

  • "TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Resolutions of the 8th Meeting of the Board of Directors in 2026Sep 5
  • "TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Convening the 2026 Semi-annual Performance Briefing and Attending the Online Collective Reception Day for Investors of Listed Companies in Tianjin JurisdictionAug 27
  • "TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Semi-annual Report for 2026Aug 15
  • "TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Routine Related Party TransactionsAug 8
All Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A news releases↗